IP Library › Patent Application 17443769
Patent Application
App. No. 17/443,769

USE OF LEVOCETIRIZINE AND MONTELUKAST IN THE TREATMENT OF TRAUMATIC INJURY

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
17/443,769
Abstract

The embodiments described herein include methods and formulations for treating lung and brain injury. The methods and formulations include, but are not limited to, methods and formulations for delivering effective concentrations of levocetirizine and montelukast to a patient in need. The methods and formulations can comprise conventional and/or modified-release elements, providing for drug delivery to the patient.

Claims (10)

1 . A method of treating traumatic injury or a symptom of traumatic injury in a patient in need thereof comprising administering an effective amount of a combination of levocetirizine and montelukast.

2 . The method of claim 1 , wherein the combination is administered at the onset of symptoms.

3 . The method of claim 1 , wherein the combination is administered at the time of diagnosis.

4 . The method of claim 1 , wherein the combination is administered in a sequential manner.

5 . The method of claim 1 , wherein the combination is administered in a substantially simultaneous manner.

6 . The method of claim 1 , further comprising the administration of an additional active agent.

7 . The method of claim 6 , wherein the additional active agent is selected from the group consisting of an antibiotic, antiviral, anti-parasitic, antifungal, vasopressor, diuretic, anticoagulant, anti-seizure medication, proton pump inhibitor, H2 receptor antagonist, antipyretic agent, anti-inflammatory drug, anti-neoplastic drug, and combinations thereof.

8 . The method of claim 6 , wherein the additional active agent is an antibiotic selected from the group consisting of vancomycin, meropenem, amoxicillin/beta clauvulanic acid, levofloxacin, piperacillin/tazobactam, ceftriaxone, clindamycin, azithromycin, trimethoprim/sulfamethoxazole, doxycycline or combinations thereof.

9 . The method of claim 1 , wherein the combination is administered to the patient by one or more of the routes consisting of enteral, intravenous, intraperitoneal, inhalation, intramuscular, subcutaneous and oral.

10 . The method of claim 1 , wherein the levocetirizine and montelukast are administered by the same route.